$FPAY
FlexShopper, Inc. Stock $fpay

$fpay Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000121390023032044 Filed on April 24, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022
Revenue	$24.53M	$21.41M	$113.1M
YoY Change	-32.88%	-31.14%	-9.86%
Cost Of Revenue	$16.14M	$17.57M	$75.94M
YoY Change	-11.35%	-6.93%	-4.09%
Gross Profit	$8.391M	$3.843M	$37.12M
YoY Change	-54.25%	-68.55%	-19.75%
Gross Profit Margin	34.21%	17.95%	32.83%
Selling, General & Admin	$5.230M	$5.537M	$24.40M
YoY Change	-28.16%	-17.58%	18.32%
% of Gross Profit	62.33%	144.09%	65.73%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.207M	$1.466M	$4.038M
YoY Change	7.63%	-92.06%	-94.72%
% of Gross Profit	14.38%	38.15%	10.88%
Operating Expenses	$26.56M	$26.89M	$119.4M
YoY Change	99.15%	137.31%	206.96%
Operating Profit	-$2.031M	-$23.04M	-$6.303M
YoY Change	-140.61%	-2695.85%	-185.59%
Interest Expense	$4.569M	-$3.825M	$11.16M
YoY Change	94.59%	176.49%	-313.06%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$6.600M	$5.161M	-$3.003M
YoY Change	-348.61%	-1140.93%	-174.01%
Income Tax	-$1.302M	-$2.743M	-$16.64M
% Of Pretax Income		-53.14%
Net Earnings	-$5.298M	$5.941M	$13.63M
YoY Change	-136.82%	838.05%	316.52%
Net Earnings / Revenue	-21.59%	27.75%	12.06%
Basic Earnings Per Share	-$0.22		$0.45
Diluted Earnings Per Share	-$0.22	$0.26	$0.44
COMMON SHARES
Basic Shares Outstanding	21.75M shares	21.75M shares	21.65M shares
Diluted Shares Outstanding	28.92M shares		22.43M shares

Balance Sheet

Concept	2023 Q2	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.373M	$6.052M	$6.052M
YoY Change	27.75%	18.79%	18.79%
Cash & Equivalents	$6.373M	$6.052M
Short-Term Investments
Other Short-Term Assets	$27.67M	$35.16M	$35.16M
YoY Change	-26.62%	-16.08%	-16.08%
Inventory
Prepaid Expenses	$3.069M	$3.489M
Receivables	$39.23M	$35.54M
Other Receivables
Total Short-Term Assets	$98.38M	$109.7M	$109.7M
YoY Change	0.09%	42.65%	42.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.831M	$8.087M	$9.493M
YoY Change	-6.05%	3.13%	21.07%
Goodwill
YoY Change
Intangibles	$14.28M	$15.16M
YoY Change		305592.52%
Long-Term Investments
YoY Change
Other Assets	$15.30M	$13.95M	$13.95M
YoY Change	24.22%	17879.58%	17879.58%
Total Long-Term Assets	$39.74M	$38.60M	$38.60M
YoY Change	82.95%	387.5%	387.5%
TOTAL ASSETS
Total Short-Term Assets	$98.38M	$109.7M	$109.7M
Total Long-Term Assets	$39.74M	$38.60M	$38.60M
Total Assets	$138.1M	$148.3M	$148.3M
YoY Change	15.09%	74.84%	74.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.005M	$6.512M	$6.512M
YoY Change	-23.6%	-18.42%	-18.42%
Accrued Expenses	$2.387M	$3.988M	$4.307M
YoY Change	-50.04%	33.49%	21.59%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.427M	$1.409M	$1.409M
YoY Change	21.31%	32.69%	32.69%
Total Short-Term Liabilities	$8.128M	$12.23M	$12.23M
YoY Change	-31.09%	-2.85%	-2.85%
LONG-TERM LIABILITIES
Long-Term Debt	$101.2M	$94.76M	$94.76M
YoY Change	30.62%	76.05%	76.05%
Other Long-Term Liabilities	$1.448M	$10.27M	$10.27M
YoY Change	712.63%	1973.19%	482.76%
Total Long-Term Liabilities	$102.7M	$105.0M	$105.0M
YoY Change	57542.54%	21110.37%	88.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.128M	$12.23M	$12.23M
Total Long-Term Liabilities	$102.7M	$105.0M	$105.0M
Total Liabilities	$110.8M	$117.3M	$117.3M
YoY Change	21.58%	70.76%	70.76%
SHAREHOLDERS EQUITY
Retained Earnings	-$37.12M	-$31.59M
YoY Change	11.76%	-30.14%
Common Stock	$2.176K	$2.176K
YoY Change	0.69%	1.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$27.29M	$31.03M	$31.03M
YoY Change
Total Liabilities & Shareholders Equity	$138.1M	$148.3M	$148.3M
YoY Change	15.09%	74.84%	74.84%

Cashflow Statement

Concept	2023 Q2	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$5.298M	$5.941M	$13.63M
YoY Change	-136.82%	838.05%	316.52%
Depreciation, Depletion And Amortization	$1.207M	$1.466M	$4.038M
YoY Change	7.63%	-92.06%	-94.72%
Cash From Operating Activities	-$128.3K	-$3.691M	-$31.24M
YoY Change	-98.91%	-70.27%	177.51%
INVESTING ACTIVITIES
Capital Expenditures	$1.535M	$2.063M	$6.498M
YoY Change	-171.95%	-238.45%	-231.29%
Acquisitions
YoY Change
Other Investing Activities		$2.938M	$2.938M
YoY Change
Cash From Investing Activities	-$1.535M	$875.2K	-$5.201M
YoY Change	-28.05%	-158.73%	5.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.827M	3.234M	$37.52M
YoY Change	-112.19%	-79.6%	194.04%
NET CHANGE
Cash From Operating Activities	-128.3K	-3.691M	-$31.24M
Cash From Investing Activities	-1.535M	875.2K	-$5.201M
Cash From Financing Activities	-1.827M	3.234M	$37.52M
Net Change In Cash	-3.491M	417.2K	$1.079M
YoY Change	-408.83%	-78.57%	-131.3%
FREE CASH FLOW
Cash From Operating Activities	-$128.3K	-$3.691M	-$31.24M
Capital Expenditures	$1.535M	$2.063M	$6.498M
Free Cash Flow	-$1.663M	-$5.755M	-$37.74M
YoY Change	-82.67%	-47.33%	498.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet		usd
CY2021	fpay	Number Of Series One Convertible Preferred Stock NumberOfSeriesOneConvertiblePreferredStock		usd
CY2021Q4	us-gaap	Fair Value Option Loans Held As Assets90 Days Or More Past Due Aggregate Difference FairValueOptionLoansHeldAsAssets90DaysOrMorePastDueAggregateDifference		usd
CY2021Q4	us-gaap	Fair Value Option Loans Held As Assets Aggregate Amount In Nonaccrual Status Aggregated Difference FairValueOptionLoansHeldAsAssetsAggregateAmountInNonaccrualStatusAggregatedDifference		usd
CY2021Q4	us-gaap	Fair Value Option Loans Held As Assets Aggregate Difference FairValueOptionLoansHeldAsAssetsAggregateDifference		usd
CY2022	fpay	Performance Share Units PerformanceShareUnits		usd
CY2021	fpay	Performance Share Units PerformanceShareUnits		usd
CY2022	fpay	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-37945
CY2022	dei	Entity Registrant Name EntityRegistrantName	FLEXSHOPPER, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-5456087
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	901 Yamato Road
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ste. 260
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Boca Raton
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33431
CY2022	dei	City Area Code CityAreaCode	(855)
CY2022	dei	Local Phone Number LocalPhoneNumber	353-9289
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2022	dei	Trading Symbol TradingSymbol	FPAY
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	11240000	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21752304	shares
CY2022	dei	Auditor Firm AuditorFirmId	248
CY2022	dei	Auditor Name AuditorName	EisnerAmper LLP
CY2022	dei	Auditor Location AuditorLocation	Iselin, New Jersey
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	6051713	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	4986559	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	121636	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	108083	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35540043	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25473154	usd
CY2022Q4	us-gaap	Securities Received As Collateral SecuritiesReceivedAsCollateral	32932504	usd
CY2021Q4	us-gaap	Securities Received As Collateral SecuritiesReceivedAsCollateral	3560108	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3489136	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1823256	usd
CY2022Q4	fpay	Lease Merchandise LeaseMerchandise	31550441	usd
CY2021Q4	fpay	Lease Merchandise LeaseMerchandise	40942112	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	109685473	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	76893272	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8086862	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5490434	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1406270	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1553330	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15162349	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4960	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	1934728	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	870060	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	12013828	usd
CY2022Q4	us-gaap	Assets Assets	148289510	usd
CY2021Q4	us-gaap	Assets Assets	84812056	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6511943	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7982180	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	310820	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	391078	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Premium Noncurrent DebtInstrumentUnamortizedPremiumNoncurrent	0	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Premium Noncurrent DebtInstrumentUnamortizedPremiumNoncurrent	1274	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	1209455	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	1053088	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3988093	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2987646	usd
CY2022Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	208001	usd
CY2021Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	172732	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12228312	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12586724	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	352252	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	413076	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	80847748	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	50061924	usd
CY2022Q4	fpay	Promissory Notes To Related Parties Net Of Current Portion PromissoryNotesToRelatedPartiesNetOfCurrentPortion	10750000	usd
CY2021Q4	fpay	Promissory Notes To Related Parties Net Of Current Portion PromissoryNotesToRelatedPartiesNetOfCurrentPortion	3750000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	1165027	usd
CY2022Q4	fpay	Promissory Note Related To Acquisition1 PromissoryNoteRelatedToAcquisition1	3158471	usd
CY2022Q4	us-gaap	Other Notes Payable OtherNotesPayable	8703684	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	495166	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1566622	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1774623	usd
CY2022Q4	us-gaap	Liabilities Liabilities	117254837	usd
CY2021Q4	us-gaap	Liabilities Liabilities	68668437	usd
CY2022Q4	fpay	Convertible Preferred Stock Series ConvertiblePreferredStockSeries	851660	usd
CY2021Q4	fpay	Convertible Preferred Stock Series ConvertiblePreferredStockSeries	851660	usd
CY2022Q4	fpay	Convertible Preferred Stock Series Two ConvertiblePreferredStockSeriesTwo	21952000	usd
CY2021Q4	fpay	Convertible Preferred Stock Series Two ConvertiblePreferredStockSeriesTwo	21952000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21750804	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21750804	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21442278	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21442278	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2176	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2144	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	39819420	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	38560117	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31590583	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-45222302	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	31034673	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16143619	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	148289510	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	84812056	usd
CY2022	fpay	Lease Revenues And Fees Net LeaseRevenuesAndFeesNet	105936072	usd
CY2021	fpay	Lease Revenues And Fees Net LeaseRevenuesAndFeesNet	124505432	usd
CY2022	fpay	Net Changes In The Fair Value Of Loans Receivable At Fair Value Amount NetChangesInTheFairValueOfLoansReceivableAtFairValueAmount	7120101	usd
CY2021	fpay	Net Changes In The Fair Value Of Loans Receivable At Fair Value Amount NetChangesInTheFairValueOfLoansReceivableAtFairValueAmount	921324	usd
CY2022	us-gaap	Revenues Revenues	113056173	usd
CY2021	us-gaap	Revenues Revenues	125426756	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	72556431	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	78669393	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	3384013	usd
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	508493	usd
CY2022	us-gaap	Marketing Expense MarketingExpense	11031695	usd
CY2021	us-gaap	Marketing Expense MarketingExpense	9129062	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	10991477	usd
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	11489208	usd
CY2022	us-gaap	Other General Expense OtherGeneralExpense	21395767	usd
CY2021	us-gaap	Other General Expense OtherGeneralExpense	18265781	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	119359383	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	118061937	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-6303210	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	7364819	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1931825	usd
CY2022	fpay	Gain On Bargain Purchase Net Of Deferred Taxes GainOnBargainPurchaseNetOfDeferredTaxes	14461274	usd
CY2022	us-gaap	Interest Expense InterestExpense	11161396	usd
CY2021	us-gaap	Interest Expense InterestExpense	5238560	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3003332	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4058084	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-16635051	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	785310	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	13631719	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3272774	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	3730580	usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2439099	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9901139	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	833675	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.45
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.44
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21646896	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21387960	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22425354	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23227964	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11154046	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1125819	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	522808	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	68172	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3272774	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16143619	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	997830	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	261505	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	13631719	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	31034673	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	13631719	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3272774	usd
CY2022	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	72556431	usd
CY2021	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	78669393	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	4769614	usd
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	2875902	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	228843	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	220816	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	19747	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	997830	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1648627	usd
CY2022	fpay	Provisions For Doubtful Accounts ProvisionsForDoubtfulAccounts	-57420480	usd
CY2021	fpay	Provisions For Doubtful Accounts ProvisionsForDoubtfulAccounts	-40342618	usd
CY2022	fpay	Gain On Sale Of Lease Receivables GainOnSaleOfLeaseReceivables	8821106	usd
CY2022	fpay	Interest In Kind Added To Promissory Notes Balance InterestInKindAddedToPromissoryNotesBalance	155093	usd
CY2021	fpay	Interest In Kind Added To Promissory Notes Balance InterestInKindAddedToPromissoryNotesBalance	9460	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-17282364	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	495166	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost	1931825	usd
CY2022	fpay	Gain On Bargain Purchase GainOnBargainPurchase	14461274	usd
CY2022	fpay	Net Changes In The Fair Value Of Loans Receivable At Fair Value NetChangesInTheFairValueOfLoansReceivableAtFairValue	9559979	usd
CY2021	fpay	Net Changes In The Fair Value Of Loans Receivable At Fair Value NetChangesInTheFairValueOfLoansReceivableAtFairValue	-248984	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	76308475	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	56738233	usd
CY2022	fpay	Increase Decrease In Loans Receivable At Fair Value IncreaseDecreaseInLoansReceivableAtFairValue	25612049	usd
CY2021	fpay	Increase Decrease In Loans Receivable At Fair Value IncreaseDecreaseInLoansReceivableAtFairValue	3221679	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1665880	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	87394	usd
CY2022	fpay	Increase Decrease In Lease Liability IncreaseDecreaseInLeaseLiability	63164760	usd
CY2021	fpay	Increase Decrease In Lease Liability IncreaseDecreaseInLeaseLiability	76789165	usd
CY2022	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-4956	usd
CY2021	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-8338	usd
CY2022	fpay	Purchase Consideration Payable Related To Acquisition PurchaseConsiderationPayableRelatedToAcquisition	164102	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-14488	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5811	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1976844	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	74561	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-80258	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-165461	usd
CY2021	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	143940	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1009468	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	331542	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-31236936	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11256031	usd
CY2022	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	2938355	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6498115	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4065384	usd
CY2022	fpay	Purchases Of Data Costs PurchasesOfDataCosts	1640885	usd
CY2021	fpay	Purchases Of Data Costs PurchasesOfDataCosts	884160	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5200645	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4949544	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	36455000	usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	19850000	usd
CY2022	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	5730000	usd
CY2021	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	6575000	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	166745	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	565273	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	261505	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	68172	usd
CY2022	fpay	Proceeds From Debt Instrument ProceedsFromDebtInstrument	7000000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	11184	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	7707	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	283266	usd
CY2022	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	9022	usd
CY2021	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	11207	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	37516288	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12758985	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1078707	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3446590	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5094642	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8541232	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6173349	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5094642	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	10289334	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4945690	usd
CY2022	fpay	Acquisition Of Loan Receivables At Fair Value AcquisitionOfLoanReceivablesAtFairValue	13320326	usd
CY2022	fpay	Acquisition Of Property And Equipment AcquisitionOfPropertyAndEquipment	136249	usd
CY2022	fpay	Acquisition Of Intangible Assets AcquisitionOfIntangibleAssets	15307894	usd
CY2022	fpay	Acquisition Of Purchase Consideration Payable Related To Acquisition AcquisitionOfPurchaseConsiderationPayableRelatedToAcquisition	8539582	usd
CY2022	fpay	Acquisition Of Accounts Payable AcquisitionOfAccountsPayable	506607	usd
CY2022	fpay	Acquisition Of Deferred Tax Liability AcquisitionOfDeferredTaxLiability	4773370	usd
CY2022	fpay	Issuance Of Promissory Note Related To Acquisition IssuanceOfPromissoryNoteRelatedToAcquisition	3421991	usd
CY2021	fpay	Lease Revenues And Fees LeaseRevenuesAndFees	124505432	usd
CY2022	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	38416	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Estimates -</b> The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6051713	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4986559	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	121636	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	108083	usd
CY2022Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	6173349	usd
CY2021Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	5094642	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	48618843	usd
CY2021Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	53176432	usd
CY2022Q4	fpay	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	13078800	usd
CY2021Q4	fpay	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	27703278	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	35540043	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	25473154	usd
CY2022	fpay	Accounts Receivable Charged Off Against Allowance AccountsReceivableChargedOffAgainstAllowance	72044958	usd
CY2021	fpay	Accounts Receivable Charged Off Against Allowance AccountsReceivableChargedOffAgainstAllowance	34777881	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	27703278	usd
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	22138541	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	57420480	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	40342618	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	72044958	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	34777881	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13078800	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	27703278	usd
CY2021	fpay	Net Incomeloss Attributable To Common And Series1 Convertible Preferred Stock NetIncomelossAttributableToCommonAndSeries1ConvertiblePreferredStock	-833675	usd
CY2022Q4	fpay	Lease Merchandise At Cost LeaseMerchandiseAtCost	62379920	usd
CY2021Q4	fpay	Lease Merchandise At Cost LeaseMerchandiseAtCost	72159063	usd
CY2022Q4	fpay	Impairment Reserve ImpairmentReserve	30829479	usd
CY2021Q4	fpay	Impairment Reserve ImpairmentReserve	31216951	usd
CY2022Q4	fpay	Lease Merchandise Net LeaseMerchandiseNet	31550441	usd
CY2021Q4	fpay	Lease Merchandise Net LeaseMerchandiseNet	40942112	usd
CY2022	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	9559979	usd
CY2021	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	248984	usd
CY2022	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	154535446	usd
CY2021	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	164848050	usd
CY2022	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	57420480	usd
CY2021	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	40342618	usd
CY2022	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	8821106	usd
CY2022	fpay	Lease Revenues And Fees LeaseRevenuesAndFees	105936072	usd
CY2022	fpay	Interest Expense Debt Including Amortization InterestExpenseDebtIncludingAmortization	227568	usd
CY2021	fpay	Interest Expense Debt Including Amortization InterestExpenseDebtIncludingAmortization	213814	usd
CY2022	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2022Q4	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	150505	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3076	usd
CY2022	us-gaap	Property Plant And Equipment Estimated Useful Lives PropertyPlantAndEquipmentEstimatedUsefulLives	7 years
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	4037936	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	2786109	usd
CY2022	us-gaap	Payments For Software PaymentsForSoftware	5240437	usd
CY2021	us-gaap	Payments For Software PaymentsForSoftware	2816939	usd
CY2021Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	4361	usd
CY2022	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	2907435	usd
CY2021	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	2317626	usd
CY2022	fpay	Net Income Attributables To Series1 Convertible Preferred Stock NetIncomeAttributablesToSeries1ConvertiblePreferredStock	-140374	usd
CY2021	fpay	Net Income Attributables To Series1 Convertible Preferred Stock NetIncomeAttributablesToSeries1ConvertiblePreferredStock	-34106	usd
CY2022	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	1640885	usd
CY2021	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	884160	usd
CY2022	fpay	Capitalized Data Costs Amortization Expense CapitalizedDataCostsAmortizationExpense	581173	usd
CY2021	fpay	Capitalized Data Costs Amortization Expense CapitalizedDataCostsAmortizationExpense	86717	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13152568	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11523917	shares
CY2022	fpay	Net Incomelosses NetIncomelosses	-13631719	usd
CY2021	fpay	Net Incomelosses NetIncomelosses	-3272774	usd
CY2022	fpay	Convertible Series2 Preferred Share Dividends ConvertibleSeries2PreferredShareDividends	-3730580	usd
CY2021	fpay	Convertible Series2 Preferred Share Dividends ConvertibleSeries2PreferredShareDividends	-2439099	usd
CY2022	fpay	Net Incomeloss Attributable To Common And Series1 Convertible Preferred Stock NetIncomelossAttributableToCommonAndSeries1ConvertiblePreferredStock	-9901139	usd
CY2021	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	25418	usd
CY2022	fpay	Net Incomeloss Attributable To Common Shares After Assumed Conversions Numerator For Diluted Eps NetIncomelossAttributableToCommonSharesAfterAssumedConversionsNumeratorForDilutedEps	9799181	usd
CY2021	fpay	Net Incomeloss Attributable To Common Shares After Assumed Conversions Numerator For Diluted Eps NetIncomelossAttributableToCommonSharesAfterAssumedConversionsNumeratorForDilutedEps	824987	usd
CY2022	fpay	Weighted Average Of Common Shares Outstanding Denominator For Basic Eps WeightedAverageOfCommonSharesOutstandingDenominatorForBasicEPS	21646896	shares
CY2021	fpay	Weighted Average Of Common Shares Outstanding Denominator For Basic Eps WeightedAverageOfCommonSharesOutstandingDenominatorForBasicEPS	21387960	shares
CY2022	fpay	Number Of Series One Convertible Preferred Stock NumberOfSeriesOneConvertiblePreferredStock	225231	usd
CY2022	fpay	Common Stock Optionsin Shares CommonStockOptionsinShares	351576	shares
CY2021	fpay	Common Stock Optionsin Shares CommonStockOptionsinShares	978978	shares
CY2022	fpay	Common Stock Warrantsin Shares CommonStockWarrantsinShares	201651	shares
CY2021	fpay	Common Stock Warrantsin Shares CommonStockWarrantsinShares	861026	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	22425354	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	23227964	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.45
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.44
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022Q4	us-gaap	Fair Value Option Loans Held As Assets90 Days Or More Past Due Aggregate Difference FairValueOptionLoansHeldAsAssets90DaysOrMorePastDueAggregateDifference	203182	usd
CY2022Q4	us-gaap	Fair Value Option Loans Held As Assets Aggregate Amount In Nonaccrual Status Aggregated Difference FairValueOptionLoansHeldAsAssetsAggregateAmountInNonaccrualStatusAggregatedDifference	1841812	usd
CY2022Q4	us-gaap	Fair Value Option Loans Held As Assets Aggregate Difference FairValueOptionLoansHeldAsAssetsAggregateDifference	6947224	usd
CY2022	fpay	Largest Benefit Percentage LargestBenefitPercentage	0.50	pure
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reclassifications</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior year balances have been reclassified to conform with the current year presentation. These reclassifications primarily include separating the prepaid expenses, right of use asset and loan revenues and fees, net of changes in fair value as separate line items. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	fpay	Operating Leases Rent Expense Monthly Rent OperatingLeasesRentExpenseMonthlyRent	2300	usd
CY2019Q1	fpay	Term Of Lease TermOfLease	P108M
CY2019Q1	us-gaap	Area Of Land AreaOfLand	21622	sqm
CY2019Q1	fpay	Conversion Of Stock Options Into Common Stock ConversionOfStockOptionsIntoCommonStock	31500	usd
CY2019Q1	us-gaap	Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage	0.03	pure
CY2021Q3	us-gaap	Payments For Rent PaymentsForRent	8800	usd
CY2022Q4	fpay	Total Lease Assets TotalLeaseAssets	1406270	usd
CY2021Q4	fpay	Total Lease Assets TotalLeaseAssets	1553330	usd
CY2022Q4	fpay	Total Lease Liabilities TotalLeaseLiabilities	1774623	usd
CY2021Q4	fpay	Total Lease Liabilities TotalLeaseLiabilities	1947355	usd
CY2022	fpay	Term Of Lease TermOfLease	P12M
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	389647	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	401463	usd
CY2022	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted		usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	405443	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	400771	usd
CY2022	fpay	Finance Lease Principal Payment FinanceLeasePrincipalPayment	11184	usd
CY2021	fpay	Finance Lease Principal Payment FinanceLeasePrincipalPayment	11184	usd
CY2022Q4	fpay	Operating Lease Future Minimum Payments Due Current OperatingLeaseFutureMinimumPaymentsDueCurrent	417606	usd
CY2022Q4	fpay	Operating Lease Future Minimum Payments Due In Two Years OperatingLeaseFutureMinimumPaymentsDueInTwoYears	430134	usd
CY2022Q4	fpay	Operating Lease Future Minimum Payments Due In Three Years OperatingLeaseFutureMinimumPaymentsDueInThreeYears	443038	usd
CY2022Q4	fpay	Operating Lease Future Minimum Payments Due In Four Years OperatingLeaseFutureMinimumPaymentsDueInFourYears	456330	usd
CY2022Q4	fpay	Operating Lease Future Minimum Payments Due In Five Years OperatingLeaseFutureMinimumPaymentsDueInFiveYears	470019	usd
CY2022Q4	fpay	Operating Lease Future Minimum Payments Due Thereafter OperatingLeaseFutureMinimumPaymentsDueThereafter	303574	usd
CY2022Q4	fpay	Operating Lease Future Minimum Payments Due OperatingLeaseFutureMinimumPaymentsDue	2520701	usd
CY2022Q4	fpay	Interest Interest	-759144	usd
CY2022Q4	fpay	Present Value Of Lease Liabilities PresentValueOfLeaseLiabilities	1761557	usd
CY2022	fpay	Schedule Of Undiscounted Finance Lease Liabilities ScheduleOfUndiscountedFinanceLeaseLiabilities	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Finance Leases</b></span></td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$ </span></td> <td style="text-align: right; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,699</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,782</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total undiscounted cash flows</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,481</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: interest</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,415</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of lease liabilities</span></td> <td> </td> <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,066</span></td> <td> </td></tr> </table>
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	9699	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	4782	usd
CY2022Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	14481	usd
CY2022	fpay	Finance Leaseinterest FinanceLeaseinterest	1415	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	13066	usd
CY2022	fpay	Principal Accrued Unpaid Interestoutstanding PrincipalAccruedUnpaidInterestoutstanding	1017826	usd
CY2021	fpay	Principal Accrued Unpaid Interestoutstanding PrincipalAccruedUnpaidInterestoutstanding	1011439	usd
CY2022	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	196338	usd
CY2021	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	148011	usd
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	211349	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24610028	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	17975664	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16523166	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12485230	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8086862	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5490434	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4037936	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2786109	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15338654	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-176305	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15162349	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	30760	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-25800	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4960	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	150505	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3076	usd
CY2022	fpay	Description Of Notes Amended And Restated DescriptionOfNotesAmendedAndRestated	This last amendment extended the maturity date from April 1, 2022 to July 1, 2024 and increased the credit commitment from $3,750,000 to $11,000,000.
CY2021Q1	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	237000	usd
CY2022Q3	fpay	Loans Percentage LoansPercentage	1	pure
CY2022Q3	fpay	Loans Percentage LoansPercentage	1	pure
CY2022	fpay	Schedule Of Covenant Requirements And Flexshoppers Actual Results ScheduleOfCovenantRequirementsAndFlexshoppersActualResults	<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Required<br/> Covenant</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Actual <br/> Position</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Equity Book Value not less than</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">9,636,387</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">31,034,673</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Liquidity greater than</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,051,713</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash greater than</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,173,350</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Consolidated Total Debt to Equity Book Value ratio not to exceed</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.25</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.14</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	fpay	Borrowed Credit Agreement BorrowedCreditAgreement	36455000	usd
CY2021	fpay	Borrowed Credit Agreement BorrowedCreditAgreement	19850000	usd
CY2022	fpay	Repaid Credit Agreement RepaidCreditAgreement	5730000	usd
CY2021	fpay	Repaid Credit Agreement RepaidCreditAgreement	6575000	usd
CY2022	fpay	Credit Agreement Interest Rate CreditAgreementInterestRate	0.04	pure
CY2020Q3	fpay	Warrant Exercise Price WarrantExercisePrice	1.6
CY2020Q3	fpay	Warrants Expiration Period WarrantsExpirationPeriod	P4Y
CY2022	fpay	Warrants Granted WarrantsGranted	320000	shares
CY2022	fpay	Issuance Of Shares And Warrants In Eauity Raise Value IssuanceOfSharesAndWarrantsInEauityRaiseValue	522808	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.63
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.85
CY2022	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedIntrinsicValue	480029	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	7333	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.22
CY2022Q4	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedIntrinsicValue	2273	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	25000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.7
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3919228	shares
CY2022	fpay	Warrant Convertible Into Common Stock WarrantConvertibleIntoCommonStock	116903	shares
CY2022	fpay	Stock Options StockOptions	997830	usd
CY2021	fpay	Stock Options StockOptions	1125819	usd
CY2022	fpay	Total Stockbased Compensation TotalStockbasedCompensation	997830	usd
CY2021	fpay	Total Stockbased Compensation TotalStockbasedCompensation	1125819	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	997830	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1125819	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	860070	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y5M15D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3080904	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.06
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1923642	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1179183	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.45
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	308526	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.97
CY2022	fpay	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2	P6Y9M10D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	52223	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	3152169	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.02
CY2022	fpay	Sharebased Compensation Arrangement By Sharebased Payment Award Option Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term3 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm3	P6Y6M7D
CY2022Q4	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Aggregate Intrinsic Value1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableAggregateIntrinsicValue1	52223	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2595700	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.92
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2491026	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	626238	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.52
CY2021	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted	74482	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	82333	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.83
CY2021	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedIntrinsicValue	151544	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	58701	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.65
CY2021Q4	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedIntrinsicValue	58285	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3080904	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.06
CY2021	fpay	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2	P6Y8M19D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1923642	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2307571	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.04
CY2021	fpay	Sharebased Compensation Arrangement By Sharebased Payment Award Option Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term3 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm3	P6Y10M13D
CY2021Q4	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Aggregate Intrinsic Value1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableAggregateIntrinsicValue1	1674967	usd
CY2022	fpay	Weighted Average Grant Fair Value WeightedAverageGrantFairValue	0.9
CY2021	fpay	Weighted Average Grant Fair Value WeightedAverageGrantFairValue	1.75
CY2022	fpay	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod1	790327	shares
CY2022	fpay	Weighted Average Grant Date Fair Value Granted WeightedAverageGrantDateFairValueGranted	P1Y6M10D
CY2022	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber1	790327	shares
CY2022	fpay	Weighted Average Grant Date Fair Value Non Vested1 WeightedAverageGrantDateFairValueNonVested1	P1Y6M10D
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-630700	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	852198	usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	-736962	usd
CY2021	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	-487093	usd
CY2022	fpay	Tax Impact On Gain On Bargain Purchase TaxImpactOnGainOnBargainPurchase	-3036868	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	123933	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-259967	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	7862	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	59168	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-12525690	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	614112	usd
CY2022	fpay	Benefit Income Other BenefitIncomeOther	163374	usd
CY2021	fpay	Benefit Income Other BenefitIncomeOther	6892	usd
CY2022	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-16635051	usd
CY2021	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	785310	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	428111	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	479956	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	3240968	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	6847189	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-9153508	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-8085957	usd
CY2022	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	989120	usd
CY2021	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	423022	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	439758	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	481312	usd
CY2022Q4	fpay	Deferred Tax Assets Tax Right Of Use Asset DeferredTaxAssetsTaxRightOfUseAsset	-348478	usd
CY2021Q4	fpay	Deferred Tax Assets Tax Right Of Use Asset DeferredTaxAssetsTaxRightOfUseAsset	-383924	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	16962	usd
CY2022Q4	us-gaap	Fair Value Concentration Of Risk Loans Receivable FairValueConcentrationOfRiskLoansReceivable	2264813	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	32394	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	32394	usd
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	2703639	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	12304134	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	11838840	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	3860104	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	343914	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	4730265	usd
CY2021Q4	fpay	Deferredtaxother Deferredtaxother	-53414	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	12013828	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11923332	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12418498	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-12013828	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	495166	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	58591117	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	8153233	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	754505	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	290144	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-13439360	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	495166	usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-3950196	usd
CY2022	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	-16635051	usd
CY2021	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	785310	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>11. CONTINGENCIES AND OTHER UNCERTAINTIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Regulatory inquiries</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the first quarter of 2021, FlexShopper, along with a number of other lease-to-own companies, received a subpoena from the California Department of Financial Protection and Innovation (the “DFPI”) requesting the production of documents and information regarding the Company’s compliance with state consumer protection laws. The Company is cooperatively engaging with the DFPI in response to its inquiry. Although the Company believes it is in compliance with all applicable consumer protection laws and regulations in California, this inquiry ultimately could lead to an enforcement action and/or a consent order, and substantial costs, including legal fees, fines, penalties, and remediation expenses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Litigation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is not involved in any current or pending material litigation. The Company could be involved in litigation incidental to the operation of the business. The Company intends to vigorously defend all matters in which the Company is named defendants, and, for insurable losses, maintain significant levels of insurance to protect against adverse judgments, claims or assessments that may affect the Company. Although the adequacy of existing insurance coverage of the outcome of any legal proceedings cannot be predicted with certainty, based on the current information available, the Company does not believe the ultimate liability associated with known claims or litigation, if any, in which the Company is involved will materially affect the Company’s consolidated financial condition or results of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Employment agreements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain executive management entered into employment agreements with the Company. The contracts are for a period of three years and renew for three successive one-year terms unless receipt of written notices by the parties. The contracts provide that such management may earn discretionary cash bonuses and equity awards, based on financial performance metrics defined each year by the Compensation Committee of the Company’s Board of Directors. Additionally, under certain termination conditions, such contracts provide for severance payments and other benefits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>COVID-19 and other similar health crisis</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has been, and may in the future, be impacted by COVID-19 or any similar pandemic or health crisis, and this could affect our results of operations, financial condition, or cash flow in the future. The extent and the effects of the impact of any of these events on the operation and financial performance of our business depend on several factors which are highly uncertain and cannot be predicted.</p>
CY2022	us-gaap	Derivative Term Of Contract DerivativeTermOfContract	P3Y
CY2020Q2	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	1914100	usd
CY2022	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	The Note matured on April 30, 2022 and bore interest at the rate of 1.00% per annum, payable monthly commencing on November 30, 2020, following an initial deferral period as specified under the PPP.
CY2021	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties		usd
CY2022	us-gaap	Dilutive Securities DilutiveSecurities		usd
CY2022Q4	fpay	Revolution Transaction Description RevolutionTransactionDescription	In consideration for the sale of the Revolution net assets, the Company issued an adjustable promissory note (“Seller Note”) with an initial principal amount of $5,000,000. The Seller Note matures on December 1, 2027, bears interest at 8% per annum and is subject to adjustment based upon the pre-tax net income of the acquired business in 2023.
CY2022	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	3421991	usd
CY2022Q4	fpay	Promissory Note Related To Acquisition PromissoryNoteRelatedToAcquisition	1165027	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	2938355	usd
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	13320326	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	136249	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets	15307894	usd
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current Other AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther	31702824	usd
CY2022Q4	fpay	Revolution Credit Facility RevolutionCreditFacility	-8539582	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	506607	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4773370	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	13819559	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	17883265	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	3421991	usd
CY2022	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	3421991	usd
CY2022	fpay	Business Combination Bargain Price BusinessCombinationBargainPrice	14461274	usd
CY2022	us-gaap	Multiemployer Plan Pension Significant Employer Contribution Under Collective Bargaining Arrangement To Total Employer Contribution Percentage MultiemployerPlanPensionSignificantEmployerContributionUnderCollectiveBargainingArrangementToTotalEmployerContributionPercentage	0.04	pure
CY2022Q4	us-gaap	Defined Benefit Plan Expected Future Employer Contributions Current Fiscal Year DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear	145161	usd
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Employer Contributions Current Fiscal Year DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear	181328	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021	fpay	Gain On Bargain Purchase Net Of Deferred Taxes GainOnBargainPurchaseNetOfDeferredTaxes		usd
CY2021	fpay	Gain On Sale Of Lease Receivables GainOnSaleOfLeaseReceivables		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost		usd
CY2021	fpay	Gain On Bargain Purchase GainOnBargainPurchase		usd
CY2021	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
CY2021	fpay	Proceeds From Debt Instrument ProceedsFromDebtInstrument		usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
CY2022Q4	fpay	Share Based Compensation Arrangement By Shares Based Payment Award Options Vested And Expected To Vest Outstanding Number1 ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber1		shares
CY2022Q4	fpay	Share Based Compensation Arrangement By Shares Based Payments Award Options Vested And Expected To Vest Outstanding Number1 ShareBasedCompensationArrangementBySharesBasedPaymentsAwardOptionsVestedAndExpectedToVestOutstandingNumber1		shares
CY2022	fpay	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod1		shares
CY2022	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod1		shares
CY2022	fpay	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod1		shares
CY2022	fpay	Share Based Compensation Arrangement By Share Based Payments Award Equity Instruments Other Than Options Vested In Period1 ShareBasedCompensationArrangementByShareBasedPaymentsAwardEquityInstrumentsOtherThanOptionsVestedInPeriod1		shares
CY2021	fpay	Tax Impact On Gain On Bargain Purchase TaxImpactOnGainOnBargainPurchase		usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities		usd
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward		usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance		usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001397047

Files In Submission

Name	View Source	Status
0001213900-23-032044-index-headers.html	Edgar Link	pending
0001213900-23-032044-index.html	Edgar Link	pending
0001213900-23-032044.txt	Edgar Link	pending
0001213900-23-032044-xbrl.zip	Edgar Link	pending
f10k2022ex21-1_flexshopper.htm	Edgar Link	pending
f10k2022ex23-1_flexshopper.htm	Edgar Link	pending
f10k2022ex23-2_flexshopper.htm	Edgar Link	pending
f10k2022ex31-1_flexshopper.htm	Edgar Link	pending
f10k2022ex32-1_flexshopper.htm	Edgar Link	pending
f10k2022_flexshopperinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fpay-20221231.xsd	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
fpay-20221231_cal.xml	Edgar Link	unprocessable
fpay-20221231_def.xml	Edgar Link	unprocessable
fpay-20221231_lab.xml	Edgar Link	unprocessable
fpay-20221231_pre.xml	Edgar Link	unprocessable
f10k2022_flexshopperinc_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FPAY
FlexShopper, Inc. Stock $fpay

2023 Q2 Form 10-K Financial Statement

#000121390023032044 Filed on April 24, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FPAY FlexShopper, Inc. Stock $fpay

2023 Q2 Form 10-K Financial Statement

#000121390023032044 Filed on April 24, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FPAY
FlexShopper, Inc. Stock $fpay